ClinicalTrials.Veeva

Menu
L

Life Clinical Trials | Coral Springs - Oncology

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Dupilumab
Rocatinlimab
VP-315
TLL018
Tirzepatide
Upadacitinib
Ixekizumab
AMG 451
Amlitelimab

Parent organization

This site is a part of Life Clinical Trials

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 8 total trials

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up)

Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Therapies spread over the skin may not...

Enrolling
Atopic Dermatitis
Drug: Upadacitinib Dose B
Drug: Upadacitinib Dose A

The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy and combination therapy treatment in adolescent parti...

Active, not recruiting
Atopic Dermatitis
Drug: Rocatinlimab
Drug: Placebo

This is a Phase 3, multicenter, open-label, pharmacokinetics (PK)/safety study.The study consists of 3 periods:* Screening period: 2 to 4 weeks.* Tre...

Enrolling
Prurigo Nodularis
Drug: Dupilumab

The main purpose of this study is to demonstrate that when participants with moderate to severe plaque psoriasis and obesity or overweight in the pre...

Active, not recruiting
Psoriasis
Obesity
Drug: Tirzepatide
Drug: Ixekizumab

This is a single group, 1-arm, long-term safety study for treatment of participants with moderate to severe atopic dermatitis (AD).The purpose of thi...

Enrolling
Dermatitis Atopic
Drug: Amlitelimab

Trial sponsors

Amgen logo
Sanofi logo
AbbVie logo
H
Lilly logo
V

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems